Opens in a new tab
Healthcare Market Research Worldwide

Therapy Intelligence™

Our Therapy Intelligence™ solution goes beyond syndicated studies, helping life sciences companies understand treatment reality by translating physician decisions, patient journeys and competitive dynamics into strategic clarity.
Talk to an Expert
Therapy Intelligence

Built on Real Clinical Practice

Leveraging real-world patient data, our Therapy Intelligence solution provides fast, robust, multi-country insights. Beyond the data, our experts partner with your team to interpret findings, identify strategic implications, and turn insights into action.
Immediate access

High-quality market evidence, ready now.

Answers in weeks, not months
No study from scratch

Skip months of study design and fieldwork.

Less effort, more impact
Therapy-specific insights

Focused on your indication, not generic market data.

Tailored to your market
Decision-ready evidence

Built to support confident business decisions.

Made to act on
How It Works

Four Intelligence Engines,
One Connected View

Scientific
Built with clinicians and disease experts around the real clinical questions that determine treatment decisions.
Built on clinical reality, not assumptions
Real-World
Powered by physician-reported patient records, capturing the full complexity of treatment pathways.
Observed patients not proxy data
Adaptive
Study content evolves in response to market dynamics.
Built to adapt, not just to report
Actionable
Identifying adoption barriers, treatment gaps and priority patient and HCP segments
Insight built to be acted on
Coverage

Therapeutic Areas We Cover

One intelligence framework delivering actionable evidence across complex, high-stakes therapy areas where strategic decisions matter most.
Strategic use cases

Turning Insight Into Strategic Decisions

Each growth lever maps to a concrete commercial decision your team needs to make, supported by data from the field.
01
Identify Growth Opportunities
Pinpoint untapped patient segments, under-treated eligible pools and white-space opportunities before your competitors do.
e.g. Under-treated pools in later lines of therapy
02
Refine Your Positioning
See precisely where your brand wins, where it stalls, and how the competitive frame should evolve as the landscape shifts.
e.g. Positioning versus emerging cell & gene therapies
03
Activate the Right HCPs
Identify over- and under-performing physicians with granular segmentation to unlock targeted adoption opportunities.
e.g. Hematologist segments slower to adopt new regimens
04
Anticipate Market Evolution
Track launches, sequence changes, access shifts and new prescriber behaviours earlier, before they move the market.
e.g. Shifting treatment sequencing as new therapies launch
Methodology

Built On Clinical Reality, Not Assumptions

Every Therapy Intelligence dataset is co-designed with leading clinicians, drawing on structured physician interviews and longitudinal patient record analysis. The result is insight that reflects actual prescribing behaviour, not survey proxies.
Study design
Co-designed with leading physicians in each therapeutic area
Expert teams
Dedicated pods of specialist analysts with deep, hands-on experience in a specific indication
Data collection
Structured interviews + real patient record abstraction
Analysis
Clinical and statistical validation with peer-review standards
Output
Publication-ready insights tailored to your strategic questions
1k+
HCPs interviewed
1k+
Patients profiled
1+
Countries covered
1+
Available indications

Ready To See What Therapy Intelligence™ Reveals For Your Brand?

Paul Taylor
Strategic Partnership Director
Manuel Guzman Martin
Vice President Commercial Global
Mélanie Marrot, PhD
Vice President Commercial France
Contact our Experts
Back

Paul Taylor

Strategic Partnership Director

Paul brings over 20 years of pharmaceutical business development and client partnership experience across Europe, the US, Japan, and Latin America. He has a long term exposure to longitudinal hospital data and strong expertise in oncology, neurology, and other complex and emerging therapeutic areas.

At APLUSA, Paul focuses on building and growing strategic client collaborations.. He works closely with clients, external partners and internal teams to create long-term value, unlock new mutually beneficial opportunities, and ensure joint initiatives translate into concrete business impact for clients.

Most people we know have been affected by cancer or a life-changing medical condition in some way. By working collaboratively and combining our efforts, we can improve patient outcomes, and we must all believe in our ability to make a meaningful difference for patients. Paul has a passion for sport (Cricket) and travel as well as trying to play golf!

Back

Manuel Guzman Martin

Vice President Commercial Global

Manuel is a senior healthcare market research and commercial leader with strong expertise in client engagement and growth. He has built his career across pharma, biotech and medtech, with a particular focus on oncology, immunology and cardio-metabolic diseases. His background spans senior roles in global consulting as well as in-house positions, giving him a grounded view of both strategy and execution.

At APLUSA, Manuel leads the global commercial organization, partnering with Key Account Directors, Customer Success Managers and Strategic Partnership Directors to drive sustainable growth by staying close to client needs and market dynamics. He works with teams to translate complex business and scientific questions into clear, decision-enabling strategies, while building long-term, trusted partnerships and ensuring high levels of client satisfaction. He also plays a key role in shaping APLUSA’s commercial strategy and international expansion.

Driven by curiosity and collaboration, Manuel is motivated by helping teams and clients turn robust insights into confident decisions that make a real impact.

Back

Mélanie Marrot, PhD

Vice President Commercial France

Mélanie is a PhD-trained scientist who moved from academic research into healthcare marketing and has built more than 15 years of experience in medical market research. She combines strong analytical depth with a practical understanding of how pharma markets work, and is known for anticipating client needs and turning complex data into clear, decision-ready insights across a wide range of therapeutic areas.

At APLUSA, Mélanie is a key client-facing leader for France, partnering closely with teams to design the right methodologies, guide studies from proposal to recommendation, and ensure consistently high scientific and strategic standards. She plays an active role in strengthening long-term client relationships, leading high-volume programs smoothly, and bringing added value through sharp interpretation and tailored recommendations.

A mountaineer at heart, Mélanie builds client relationships as true partnerships, grounded in trust, collaboration, and shared ambition, bringing the resilience, discipline, and adaptability of the mountains to every project.

Back

Complete My Registration

Therapy Intelligence™
Back

Share Your Feedback

Therapy Intelligence™
Back

Cancel Your Registration

Therapy Intelligence™
Back

Add to Your Calendar

Therapy Intelligence™

Google Calendar icon showing date 31
Google Calendar
Microsoft Power Automate and Outlook logos
Outlook (Personal)
Solid orange background with thin black bottom edge
Outlook (Professional)
Back

Talk to a Strategic Expert

Schedule your session to gain clear, actionable next steps and expert guidance tailored to your strategic goals.
Back

Talk to an Expert

Do you have a specific question, want to discuss a project, or just want to find out more details about one of our services?
Back

Choose Language

Back

Don’t Miss Our Next Academy Session

Get updates on upcoming training in healthcare market research and improve how your team manages insights.
Back

Don’t Miss Our Next Briefing

Join our briefings to connect and explore hot topics in pharma. Sign up to get notified about new sessions.
Back

Back

Subscribe to Our Newsletter

Stay ahead with impactful insights, the latest news from APLUSA, and updates on our events, both the ones we attend and the ones we host.